Chen Yingxin, Gao Minghong, Duncan Joshua K, Ran Di, Roe Denise J, Belin Michael W, Wang Mingwu
Department of Ophthalmology, The General Hospital of Shenyang Military Command, Shenyang, Liaoning 110016, P.R. China.
Department of Ophthalmology and Visual Science, College of Medicine, The University of Arizona, Tucson, AZ 85711, USA.
Exp Ther Med. 2016 Nov;12(5):3014-3020. doi: 10.3892/etm.2016.3699. Epub 2016 Sep 13.
The aim of the present study was to investigate the efficacy of a novel surgical intervention, excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay (EKCAI), for the treatment of recalcitrant filamentary fungal keratitis. A retrospective analysis was performed of patients who underwent excisional keratectomy combined with conjunctival flap inlay (EKCFI), EKCAI or therapeutic penetrating keratoplasty (TPK) from January 2006 to January 2011. Recalcitrance was determined as being unresponsive to standard medical antifungal therapy for at ≥1 week. Outcome measures among the three intervention modalities were compared. A total of 128 patients had a follow-up of ≥1 year after the primary intervention. The success rates of interventions at 1-year follow-up were 58.33% in the EKCFI group, 88.37% in the EKCAI group and 93.44% in the TPK group (P<0.0002). The preoperative visual acuity of the three groups were similar (P=0.6458), while the postoperative best-corrected visual acuity (BCVA) of patients without recurrence was significantly different among the three groups 3 months after surgery. The best postoperative BCVA was found in the TPK group, while the worst was in the EKCFI group. In conclusion, EKCAI does not require donor cornea, is straightforward surgically, and has a favorable success rate compared with EKCFI.
本研究的目的是调查一种新型手术干预措施,即切除性角膜切除术联合局部冷冻疗法及羊膜嵌入术(EKCAI)治疗顽固性丝状真菌性角膜炎的疗效。对2006年1月至2011年1月期间接受切除性角膜切除术联合结膜瓣嵌入术(EKCFI)、EKCAI或治疗性穿透性角膜移植术(TPK)的患者进行了回顾性分析。顽固性被定义为对标准抗真菌药物治疗至少1周无反应。比较了三种干预方式的结果指标。共有128例患者在初次干预后进行了≥1年的随访。EKCFI组1年随访时干预成功率为58.33%,EKCAI组为88.37%,TPK组为93.44%(P<0.0002)。三组术前视力相似(P=0.6458),而术后无复发患者的最佳矫正视力(BCVA)在术后3个月时三组间有显著差异。术后最佳BCVA在TPK组,最差在EKCFI组。总之,EKCAI不需要供体角膜,手术操作简单,与EKCFI相比成功率较高。